Saturna Capital Corp Novartis Ag Transaction History

Saturna Capital Corp

  • $7.24 Billion
  • Q4 2024

A detailed history of Saturna Capital Corp transactions in Novartis Ag stock. As of the latest transaction made, Saturna Capital Corp holds 320,266 shares of NVS stock, worth $34.8 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares
320,266
Previous 318,018 0.71%
Holding current value
$34.8 Million
Previous $36.6 Million 14.8%
% of portfolio
0.43%
Previous 0.49%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 07, 2025
BUY
$96.78 - $117.18 $217,561 - $263,420
2,248 Added 0.71%
320,266 $31.2 Million
Q3 2024

Nov 05, 2024
SELL
$106.13 - $120.89 $890,961 - $1.01 Million
-8,395 Reduced 2.57%
318,018 $36.6 Million
Q2 2024

Jul 31, 2024
SELL
$92.57 - $107.37 $136,170 - $157,941
-1,471 Reduced 0.45%
326,413 $34.7 Million
Q1 2024

May 13, 2024
BUY
$95.27 - $108.47 $21,721 - $24,731
228 Added 0.07%
327,884 $31.7 Million
Q4 2023

Feb 06, 2024
SELL
$92.27 - $101.54 $166,547 - $183,279
-1,805 Reduced 0.55%
327,656 $33.1 Million
Q3 2023

Nov 14, 2023
BUY
$94.73 - $105.13 $1.69 Million - $1.87 Million
17,795 Added 5.71%
329,461 $33.6 Million
Q2 2023

Aug 04, 2023
BUY
$92.52 - $104.91 $129,528 - $146,874
1,400 Added 0.45%
311,666 $31.5 Million
Q1 2023

May 15, 2023
SELL
$80.03 - $92.81 $34,412 - $39,908
-430 Reduced 0.14%
310,266 $28.5 Million
Q4 2022

Feb 09, 2023
SELL
$75.55 - $92.52 $1.17 Million - $1.44 Million
-15,519 Reduced 4.76%
310,696 $28.2 Million
Q3 2022

Nov 10, 2022
BUY
$74.61 - $87.26 $19,174 - $22,425
257 Added 0.08%
326,215 $24.8 Million
Q2 2022

Aug 12, 2022
BUY
$80.52 - $93.75 $17,714 - $20,625
220 Added 0.07%
325,958 $27.6 Million
Q1 2022

May 10, 2022
BUY
$80.11 - $90.62 $449,417 - $508,378
5,610 Added 1.75%
325,738 $28.6 Million
Q4 2021

Feb 09, 2022
SELL
$79.7 - $88.13 $91,655 - $101,349
-1,150 Reduced 0.36%
320,128 $28.7 Million
Q3 2021

Nov 08, 2021
BUY
$81.78 - $95.14 $3.08 Million - $3.58 Million
37,605 Added 13.26%
321,278 $26.3 Million
Q2 2021

Aug 11, 2021
BUY
$85.24 - $94.15 $230,148 - $254,205
2,700 Added 0.96%
283,673 $25.9 Million
Q1 2021

May 14, 2021
SELL
$83.5 - $98.47 $1.31 Million - $1.54 Million
-15,680 Reduced 5.29%
280,973 $24 Million
Q4 2020

Feb 12, 2021
BUY
$78.07 - $94.43 $35,912 - $43,437
460 Added 0.16%
296,653 $28 Million
Q3 2020

Nov 10, 2020
BUY
$82.14 - $91.0 $32,034 - $35,490
390 Added 0.13%
296,193 $25.8 Million
Q2 2020

Aug 14, 2020
BUY
$80.93 - $91.1 $32,372 - $36,440
400 Added 0.14%
295,803 $25.8 Million
Q1 2020

May 14, 2020
BUY
$70.67 - $99.01 $401,052 - $561,881
5,675 Added 1.96%
295,403 $25.9 Million
Q4 2019

Feb 13, 2020
BUY
$84.35 - $95.37 $118,089 - $133,518
1,400 Added 0.49%
289,728 $27.4 Million
Q3 2019

Nov 14, 2019
BUY
$85.54 - $94.26 $156,880 - $172,872
1,834 Added 0.64%
288,328 $25.1 Million
Q2 2019

Jul 31, 2019
BUY
$75.4 - $92.8 $3,770 - $4,640
50 Added 0.02%
286,494 $26.2 Million
Q1 2019

May 15, 2019
SELL
$75.32 - $86.15 $224,754 - $257,071
-2,984 Reduced 1.03%
286,444 $27.5 Million
Q4 2018

Feb 08, 2019
BUY
$73.66 - $82.02 $3,683 - $4,101
50 Added 0.02%
289,428 $24.8 Million
Q3 2018

Nov 13, 2018
SELL
$66.94 - $77.43 $16,735 - $19,357
-250 Reduced 0.09%
289,378 $24.9 Million
Q2 2018

Aug 02, 2018
SELL
$64.91 - $73.36 $25.3 Million - $28.6 Million
-389,600 Reduced 57.36%
289,628 $21.9 Million
Q1 2018

May 10, 2018
BUY
$70.39 - $84.15 $21,117 - $25,245
300 Added 0.04%
679,228 $54.9 Million
Q3 2017

Nov 14, 2017
SELL
$74.14 - $77.27 $450,400 - $469,415
-6,075 Reduced 0.89%
678,928 $58.3 Million
Q2 2017

Aug 14, 2017
BUY
N/A
685,003
685,003 $57.2 Million

Others Institutions Holding NVS

# of Institutions
1,479
Shares Held
134M
Call Options Held
1.31M
Put Options Held
1.56M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $234B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Saturna Capital Corp Portfolio

Follow Saturna Capital Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Saturna Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Saturna Capital Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email